Potential Tumor Suppressor Role for the c-Myb Oncogene in Luminal Breast Cancer

od Thorner, Aaron R., Parker, Joel S., Hoadley, Katherine A., Perou, Charles M.
Izdano 2010

Mitochondrial HEP27 Is a c-Myb Target Gene That Inhibits Mdm2 and Stabilizes p53

od Deisenroth, Chad, Thorner, Aaron R., Enomoto, Takeharu, Perou, Charles M., Zhang, Yanping
Izdano 2010

Blood collection in cell-stabilizing tubes does not impact germline DNA quality for pediatric patients

od Wollison, Bruce M., Thai, Edwin, Mckinney, Aimee, Ward, Abigail, Clapp, Andrea, Clinton, Catherine, Nag, Anwesha, Thorner, Aaron R., Gastier-Foster, Julie M., Crompton, Brian D.
Izdano u PLoS One (2017)

Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies

od Magnes, Teresa, Wagner, Sandro, Thorner, Aaron R., Neureiter, Daniel, Klieser, Eckhard, Rinnerthaler, Gabriel, Weiss, Lukas, Huemer, Florian, Schlick, Konstantin, Zaborsky, Nadja, Steiner, Markus, Greil, Richard, Egle, Alexander, Melchardt, Thomas
Izdano u Cancers (Basel) (2021)

Src Mutation Induces Acquired Lapatinib Resistance in ERBB2-Amplified Human Gastroesophageal Adenocarcinoma Models

od Hong, Yong Sang, Kim, Jihun, Pectasides, Eirini, Fox, Cameron, Hong, Seung-Woo, Ma, Qiuping, Wong, Gabrielle S., Peng, Shouyong, Stachler, Matthew D., Thorner, Aaron R., Van Hummelen, Paul, Bass, Adam J.
Izdano 2014

Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing

od Tyburczy, Magdalena E., Dies, Kira A., Glass, Jennifer, Camposano, Susana, Chekaluk, Yvonne, Thorner, Aaron R., Lin, Ling, Krueger, Darcy, Franz, David N., Thiele, Elizabeth A., Sahin, Mustafa, Kwiatkowski, David J.
Izdano u PLoS Genet (2015)

Detection of Circulating Tumor DNA in Patients With Leiomyosarcoma With Progressive Disease

od Hemming, Matthew L., Klega, Kelly, Rhoades, Justin, Ha, Gavin, Acker, Kate E., Andersen, Jessica L., Thai, Edwin, Nag, Anwesha, Thorner, Aaron R., Raut, Chandrajit P., George, Suzanne, Crompton, Brian D.
Izdano u JCO Precis Oncol (2019)

Characterization of the Neuroendocrine Tumor Immune Microenvironment

od da Silva, Annacarolina, Bowden, Michaela, Zhang, Sui, Masugi, Yohei, Thorner, Aaron R., Herbert, Zachary T., Zhou, Chensheng Willa, Brais, Lauren, Chan, Jennifer A., Hodi, F. Stephen, Rodig, Scott, Ogino, Shuji, Kulke, Matthew H.
Izdano u Pancreas (2018)

Unique, dual-indexed sequencing adapters with UMIs effectively eliminate index cross-talk and significantly improve sensitivity of massively parallel sequencing

od MacConaill, Laura E., Burns, Robert T., Nag, Anwesha, Coleman, Haley A., Slevin, Michael K., Giorda, Kristina, Light, Madelyn, Lai, Kevin, Jarosz, Mirna, McNeill, Matthew S., Ducar, Matthew D., Meyerson, Matthew, Thorner, Aaron R.
Izdano u BMC Genomics (2018)

BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers

od Abo, Ryan P., Ducar, Matthew, Garcia, Elizabeth P., Thorner, Aaron R., Rojas-Rudilla, Vanesa, Lin, Ling, Sholl, Lynette M., Hahn, William C., Meyerson, Matthew, Lindeman, Neal I., Van Hummelen, Paul, MacConaill, Laura E.
Izdano u Nucleic Acids Res (2015)

Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors

od Klega, Kelly, Imamovic-Tuco, Alma, Ha, Gavin, Clapp, Andrea N., Meyer, Stephanie, Ward, Abigail, Clinton, Catherine, Nag, Anwesha, Van Allen, Eliezer, Mullen, Elizabeth, DuBois, Steven G., Janeway, Katherine, Meyerson, Matthew, Thorner, Aaron R., Crompton, Brian D.
Izdano u JCO Precis Oncol (2018)

Cas9 activates the p53 pathway and selects for p53-inactivating mutations

od Enache, Oana M., Rendo, Veronica, Abdusamad, Mai, Lam, Daniel, Davison, Desiree, Pal, Sangita, Currimjee, Naomi, Hess, Julian, Pantel, Sasha, Nag, Anwesha, Thorner, Aaron R., Doench, John G., Vazquez, Francisca, Beroukhim, Rameen, Golub, Todd R., Ben-David, Uri
Izdano u Nat Genet (2020)

Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease

od Wang, Jing, Iwasaki, Hiromi, Krivtsov, Andrei, Febbo, Phillip G, Thorner, Aaron R, Ernst, Patricia, Anastasiadou, Ema, Kutok, Jeffery L, Kogan, Scott C, Zinkel, Sandra S, Fisher, Jill K, Hess, Jay L, Golub, Todd R, Armstrong, Scott A, Akashi, Koichi, Korsmeyer, Stanley J
Izdano 2005

Clinical and mutational spectrum of highly differentiated, PAX:FOXO1 fusion-negative rhabdomyosarcoma – a report from the Children’s Oncology Group

od Teot, Lisa A., Schneider, Michaela, Thorner, Aaron R., Tian, Jing, Chi, Yueh-Yun, Ducar, Matthew, Lin, Ling, Wlodarski, Marcin, Grier, Holcombe E, Fletcher, Christopher DM, van Hummelen, Paul, Skapek, Stephen X, Hawkins, Douglas S, Wagers, Amy J, Rodriguez-Galindo, Carlos, Hettmer, Simone
Izdano u Cancer (2018)

Detection of Mutations in Barrett’s Esophagus Before Progression to High-grade Dysplasia or Adenocarcinoma

od Stachler, Matthew D, Camarda, Nicholas D, Deitrick, Christopher, Kim, Anthony, Agoston, Agoston T, Odze, Robert D, Hornick, Jason L, Nag, Anwesha, Thorner, Aaron R, Ducar, Matthew, Noffsinger, Amy, Lash, Richard H, Redston, Mark, Carter, Scott L, Davison, Jon M, Bass, Adam J
Izdano u Gastroenterology (2018)

Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade

od Chapuy, Bjoern, Stewart, Chip, Dunford, Andrew J., Kim, Jaegil, Wienand, Kirsty, Kamburov, Atanas, Griffin, Gabriel K., Chen, Pei-Hsuan, Lako, Ana, Redd, Robert A., Cote, Claire M., Ducar, Matthew D., Thorner, Aaron R., Rodig, Scott J., Getz, Gad, Shipp, Margaret A.
Izdano u Blood (2019)

Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma

od Kim, Jihun, Fox, Cameron, Peng, Shouyong, Pusung, Mark, Pectasides, Eirini, Matthee, Eric, Hong, Yong Sang, Do, In-Gu, Jang, Jiryeon, Thorner, Aaron R., Van Hummelen, Paul, Rustgi, Anil K., Wong, Kwok-Kin, Zhou, Zhongren, Tang, Ping, Kim, Kyoung-Mee, Lee, Jeeyun, Bass, Adam J.
Izdano u J Clin Invest (2014)

RAS-MAPK reactivation facilitates acquired resistance in FGFR1-amplified lung cancer and underlies a rationale for upfront FGFR-MEK blockade

od Bockorny, Bruno, Rusan, Maria, Chen, Wankun, Liao, Rachel G., Li, Yvonne, Piccioni, Federica, Wang, Jun, Tan, Li, Thorner, Aaron R., Li, Tianxia, Zhang, Yanxi, Miao, Changhong, Ovesen, Therese, Shapiro, Geoffrey I., Kwiatkowski, David J., Gray, Nathanael S., Meyerson, Matthew, Hammerman, Peter S., Bass, Adam J.
Izdano u Mol Cancer Ther (2018)

Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma

od Starrett, Gabriel J., Thakuria, Manisha, Chen, Tianqi, Marcelus, Christina, Cheng, Jingwei, Nomburg, Jason, Thorner, Aaron R., Slevin, Michael K., Powers, Winslow, Burns, Robert T., Perry, Caitlin, Piris, Adriano, Kuo, Frank C., Rabinowits, Guilherme, Giobbie-Hurder, Anita, MacConaill, Laura E., DeCaprio, James A.
Izdano u Genome Med (2020)

Generalised mosaicism for TSC2 mutation in isolated lymphangioleiomyomatosis

od Ogórek, Barbara, Hamieh, Lana, Lasseter, Kathryn, Bagwe, Shefali, Machado, Tania, Herranz-Ors, Carmen, Thorner, Aaron R., Nag, Anwesha, Gulleman, Peter, Giannikou, Krinio, Young, Lisa R., Pujana, Miquel Àngel, Darling, Thomas N., El-Chemaly, Souheil, Moss, Joel, Henske, Elizabeth P., Kwiatkowski, David J.
Izdano u Eur Respir J (2019)